5,800€
1,75%
Echtzeit-Aktienkurs Ascentage Pharma Group International
Bid:
Ask:
Echtzeit-Chart der Ascentage Pharma Group International Aktie
Börsenkurse Ascentage Pharma Group International
| Börse Frankfurt | - | - | - | - | 5,800€ | 0,87% |
| Börse Stuttgart | - | - | - | - | 5,800€ | 1,75% |
| Lang & Schwarz | - | - | - | - | 5,800€ | -2,11% |
Profil der Ascentage Pharma Group International Aktie
Ascentage Pharma Group International Co., Ltd. is a clinical-stage biotechnology company. It engages in the development of novel therapies for cancers, hepatitis B virus, or HBV, and age-related diseases. The company was founded by Da Jun Yang, Wang Shao Meng and Ming Guo in May 2009 and is headquartered in Suzhou, China.